(Q84805377)
Statements
Phase II clinical trial of first or second-line treatment with bortezomib in patients with malignant pleural mesothelioma (English)
Dean A Fennell
Cliona McDowell
Sara Busacca
Glen Webb
Brian Moulton
Andrew Cakana
Kenneth J O'Byrne
Jan V Meerbeeck
Paul Donnellan
John McCaffrey
1 September 2012